Market Introduction
The North America plasma fractionation market is divided into the US, Canada, and Mexico. The growth of market is widely attributed by the growing application of coagulation factors concentrates, clotting factor concentrates and other plasma derived products to treat various hematological disorders such as hemophilia A, hemophilia B. Moreover, the growth of market in Canada is expected to grow due to increasing prevalence of multiple sclerosis and other neurological disorders. In addition, in Mexico, the market is estimated to grow owing to increasing awareness about blood and related disorders, immunological disorders along with rising awareness about plasma derived therapies in the treatment of chronic disorders.
North America Plasma Fractionation Market The COVID-19 pandemic is creating unprecedented operational and clinical challenges for healthcare institutions in the region. Moreover, the shift of priorities from chronic diseases and disorders treatments to COVID-19 diagnosis and treatment devices is leading to a decline in market growth up to a certain extent. North America Plasma Fractionation Market Although no specific drug therapy for COVID-19 has been approved, convalescent plasma therapy is expected to improve the survival rate of COVID-19 patients based on the results of a number of clinical trials. For instance, in North America, the food and drug administration has approved the emergency use authorization of convalescent plasma for the treatment and care of COVID-19 patients. The EUA, i.e., emergency use authorization, has authorized the distribution of convalescent plasma in the US for treating suspected and confirmed COVID-19 patients. Thus, the emergency use of convalescent plasma for treating COVID-19 patients is leading to a positive impact on market growth.
๐ ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐จ๐ฉ๐ฒ@ https://www.businessmarketinsights.com/sample/TIPRE00026277
Market Overview and Dynamics
The plasma fractionation market in North America is expected to grow from US$ 9,484.91 million in 2021 to US$ 14,740.90 million by 2028; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028. The market players associated with metabolomics are actively exploring the possible innovative technologies to facilitate researchers and medical care as the plasma containing the essential components to treat a disease, such as antibodies. North America Plasma Fractionation Market Various studies are being carried out on the possible applications of plasma for illnesses that are difficult to cure by employing traditional approaches. Moreover, rising awareness about the advantages of blood donation and applications of plasma among people is expected to open new scope for the market.
Key Market Segments
North America plasma fractionation market is segmented into product, application, end user, and country. The North America plasma fractionation market, based on product, has been segmented into immunoglobulin, albumin, coagulation factor concentrates, protease inhibitors, and others. The immunoglobulin segment is likely to hold the largest share of the market in 2021. The North America plasma fractionation market, based on application is segmented into neurology, immunology, hematology, critical care, pulmonology, and others. In 2021, the Neurology segment is likely to hold the largest share of the market. The North America plasma fractionation market, based on end user is segmented into hospitals and clinics, clinical research laboratories, academic institutes. In 2021, the hospitals and clinics segment is likely to hold the largest share of the market. Based on country, the North America plasma fractionation market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2020.
๐๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ง๐ค @ https://www.businessmarketinsights.com/reports/north-america-plasma-fractionation-market
๐๐ก๐ ๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
Bharat Serums and Vaccines Limited (BSV)
Bio Products Laboratory Ltd.
CSL Limited
Grifols, S.A.
Kedrion S.p.A
Octapharma AG
SK Plasma
Key Drivers of Market Growth
1.Rising Demand for Plasma-Derived Therapies: North America Plasma Fractionation Market Plasma-derived therapies are essential for treating a variety of chronic and acute conditions. For example, immunoglobulins are used to treat autoimmune disorders, while clotting factors are essential for individuals with hemophilia. With an increasing number of people being diagnosed with these conditions, the demand for plasma-derived therapies has risen, directly contributing to market growth.
2.Technological Advancements: The plasma fractionation process has evolved significantly in recent years. Advances in technologies such as affinity chromatography, viral inactivation methods, and continuous processing systems have improved the yield and quality of plasma-derived products. These innovations have made plasma fractionation more efficient, allowing producers to meet growing demand while maintaining safety and quality standards.
3.Aging Population: North America Plasma Fractionation Market The aging population in North America is another key factor driving the market. As people age, the incidence of conditions that require plasma-derived therapies, such as immune deficiencies, clotting disorders, and trauma, increases. This demographic shift has resulted in a higher demand for plasma products, further driving market growth.
4.Increased Plasma Donations: Both the United States and Canada have established systems that encourage plasma donation, which is vital for the fractionation process. The increase in plasma donations has ensured a steady supply of raw material, allowing the industry to meet the rising demand for plasma-derived products.
5.Awareness and Education: North America Plasma Fractionation Market Public awareness campaigns and educational efforts have played a critical role in increasing the number of plasma donations. Organizations such as the American Red Cross and Canadian Blood Services have been instrumental in educating the public about the importance of plasma donation, ensuring that the fractionation market continues to receive a steady supply of plasma.
Application Segmentation
- Neurology: The neurology segment is expected to hold the largest market share in 2021. Plasma-derived immunoglobulins are increasingly used to treat neurological disorders, such as multiple sclerosis and Guillain-Barrรฉ syndrome. The rising prevalence of neurological disorders in North America is a major factor driving the demand for these therapies.
- Immunology: Plasma-derived products are also crucial for immunology, particularly in the treatment of autoimmune diseases and immune deficiencies. Immunoglobulins, in particular, are widely used in immunology to manage diseases like chronic inflammatory demyelinating polyneuropathy (CIDP) and primary immune deficiencies.
- Hematology: Coagulation factor concentrates play a vital role in hematology, particularly for the management of bleeding disorders like hemophilia. Hematological treatments are a significant part of the plasma fractionation market, and demand for these products is expected to continue to grow.
- Critical Care: Plasma-derived albumin and clotting factors are essential in critical care, particularly for patients suffering from severe trauma, burns, or liver failure. These products help maintain blood volume, treat shock, and stabilize patients in critical conditions, driving demand in this application segment.
- Pulmonology: The pulmonology segment includes plasma-derived therapies for respiratory disorders such as alpha-1 antitrypsin deficiency. As awareness of these disorders grows, demand for plasma-based treatments is likely to increase.
- Others: This category encompasses various niche therapeutic areas, including dermatology and nephrology, where plasma-derived products are used to treat specific diseases or conditions. Although this segment is smaller, ongoing research may lead to increased applications of plasma therapies in additional medical fields.
3. End-User Segmentation
- Hospitals and Clinics: Hospitals and clinics are expected to be the largest end users of plasma-derived products in 2021. These facilities provide critical care and specialized treatments for a wide range of patients requiring plasma-based therapies. The significant volume of plasma products consumed in hospitals, especially for treating bleeding disorders, immunodeficiencies, and trauma patients, is a major driver of this segment.
- Clinical Research Laboratories: Clinical research laboratories are important consumers of plasma-derived products, particularly for research and the development of new therapies. These laboratories work on clinical trials to test the efficacy of plasma products for treating a variety of diseases, driving demand for specific plasma fractions.
- Academic Institutes: Academic institutions, especially those focused on medical research, use plasma-derived products for educational and research purposes. While this segment holds a smaller share of the market compared to hospitals and clinics, it contributes to the ongoing development of plasma-based treatments.
4. Geographic Segmentation
- United States: The U.S. is the largest contributor to the North American plasma fractionation market. The country has an established healthcare system, a robust plasma donation network, and a high demand for plasma-derived products. U.S. healthcare policies and the approval of plasma-derived therapies by the FDA also play a critical role in the expansion of this market.
- Canada: Canadaโs plasma fractionation market is growing steadily, particularly due to the increasing prevalence of neurological and autoimmune disorders, which drive demand for immunoglobulins and other plasma-derived therapies. The country’s public healthcare system and increased awareness of plasma donation have also contributed to market growth.
- Mexico: Mexico is witnessing an emerging demand for plasma-derived therapies, largely driven by rising awareness of blood and immunological disorders. As healthcare infrastructure improves and access to treatment becomes more widespread, the market in Mexico is expected to grow, albeit at a slower pace compared to the U.S. and Canada.
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
You can see this-
Europe Industrial Gloves Market- https://postyourarticle.com/europe-industrial-gloves-market-global-analysis-size-share-growth-trends-and-forecast-2022-2028/
Europe Augmented Reality and Virtual Reality Market- https://www.globalpostnews.com/uncategorized/europe-augmented-reality-and-virtual-reality-market-by-key-players-and-forecasts-2022-2028/
Europe Sodium Benzoate Market- https://www.openpr.com/news/3911408/europe-sodium-benzoate-market-key-players-growth-trends
Europe EV Charging Infrastructure Market- https://fortunetelleroracle.com/g-blog/europe-ev-charging-infrastructure-market-global-analysis–size–share–growth–trends-and-forecast-2022—2028-1027758
